Red Lake: The High-Grade Gold Capital of the World
Source: Visual Capitalist  (3/6/15)
Every major gold-producing country has an iconic gold-producing trend that is synonymous with prosperity. South Africa has the Witwatersrand Basin and the United States has the Carlin Trend in Nevada. While Canada has had many prolific gold-producing regions over the years, including many famous gold rushes, lately the gold capital of Canada rests in Red Lake, Ontario. More >

Contrarian Steve Palmer's Balancing Act Stretches from Western Canada to the East China Sea
Source: Peter Byrne of The Energy Report  (3/5/15)
Building a small-cap energy portfolio that maintains balance in turbulence requires the ability to spot junior firms with solid backbones. Steve Palmer of AlphaNorth Asset Management has made a career of spotting companies loaded with value, and he tells The Energy Report not only what he looks for, but also where he has found it. More >

Galaxy Resources: A New Focus to Meet the Coming Lithium Demand
Source: Kevin Michael Grace  (3/5/15)
Just two years ago, Galaxy Resources was overleveraged and unfocused. It had lost the support of the market and its shareholders. Today, as Managing Director Anthony Tse explains in this interview with The Energy Report, a new management team has exerted fiscal discipline, consolidated assets and focused the company on its world-class Sal de Vida lithium project in Argentina, positioning Galaxy to supply a metal critical to the explosion in demand for modern electronics and transportation. More >

What to Look for in Companies Navigating Drug Approval Processes on Both Sides of the Pond
Source: Jim Patrick of The Life Sciences Report  (3/5/15)
What moves biotech stocks the most? Is what moves them different in the U.S. than it is in Europe? According to the Small-Cap Biotech Watchlist, which The Life Sciences Report unveils at the Biotech Showcase each year, catalysts move stock prices. . .and some catalysts move stocks more than others. That is why, to create the Watchlist, we called on experts to look into their coverage universes for companies with expected announcements, and pick out the names with the most to gain. And everyone can follow along, all year, using the real-time Portfolio Tracker. More >

Profit Play from Massive Pharma M&A
Source: Kyle Anderson, Money Morning  (3/5/15)
Before today's AbbVie/Pharmacyclics deal, more than $35B had been spent on global healthcare mergers and acquisitions in 2015. That was up 124% from last year. Today's deal pushes that total over $57B. More >

How Alan Leong of BioWatch News Keeps Successful Biotech Investing Simple
Source: George S. Mack of The Life Sciences Report  (3/4/15)
Biotechnology can be daunting to comprehend, but understanding is critical to successful investment. BioWatch News Founder Alan Leong has a nose for growth names, and his goal is to make their technology platforms clear to investors who might not be able to make sense of peer-reviewed scientific literature but want the big upside that science promises. In this interview with The Life Sciences Report, Leong brings seven micro-cap names with massive potential to investors' attention. More >

How to Position Your Portfolio for the Coming Gold Upturn: AlphaStox's Etienne Moshevich
Source: Peter Byrne of The Gold Report  (3/4/15)
The world needs gold, says AlphaStox's Etienne Moshevich, and while it has been out of favor for the last few years, a series of macro factors point to its uptrend. In this interview with The Gold Report, Moshevich discusses 11 gold, manganese and graphite companies with management teams that have the skills to ride the wave to create shareholder value. More >

One Target with Multiple Shots on Goal: Can-Fite BioPharma CEO Pnina Fishman
  (3/4/15)
The target is a single receptor found only on abnormal cells—cancer cells and cells responsible for inflammatory diseases such as psoriasis. The weapon is a platform technology developed by Can-Fite BioPharma Ltd. under the guidance of Scientific Founder and CEO Pnina Fishman and her team. The company is developing an arsenal of therapies approaching the final stages of clinical trials, and in this interview with The Life Sciences Report, Fishman describes the catalysts and candidates that make Can-Fite a strong bet for investors. More >

Juniors Do It Better than Seniors
Source: Kip Keen, Mineweb  (3/4/15)
"Research suggests juniors hold their own in discovery." More >

Want to Stay Out of Trouble, Pharma? Compliance, Disclosure Are Key: SEC Enforcer
Source: Carly Helfand, FiercePharma  (3/4/15)
"The Securities and Exchange Commission sees a few places where you might get yourselves into sticky situations. But there's an easy way to avoid trouble, and that's to beef up compliance and disclosure." More >

Gareth Hatch: New REE Export Rules Inside China Level the International Playing Field
Source: Brian Sylvester of The Mining Report  (3/3/15)
The era of rare earth elements export quotas and tariffs in China will soon be over and that could ultimately mean a new era of higher prices for REEs inside China, says Gareth Hatch, founding principal of Technology Metals Research and president of Innovation Metals Corp. Chinese REE producers are now subject to much higher environmental standards, which could further level the playing field for non-Chinese REE producers. In this interview with The Mining Report, Hatch discusses some of the latest REE processing technologies, companies with promising REE projects and other companies looking to produce battery-grade graphite.
More >

Why Miners with Positive Cash Flow Deserve Your Attention: Philip Ker
Source: Brian Sylvester of The Gold Report  (3/2/15)
Cash flow. Cash Flow. Cash flow. That's where investors should focus in 2015, says Philip Ker, mining analyst with PI Financial. Ker says that Canadian and Mexican gold producers are generating greater cash flow owing to a stronger U.S. greenback and more finely tuned mine plans. In this interview with The Gold Report, he shares his top stock pick for 2015 and some equity stories that could unlock further shareholder value with the drill bit. More >

A Fickle Exploration Ranking
Source: Kip Keen, Mineweb  (3/2/15)
"If we're getting a perspective on exploration potential in a more perfect world without major obstacles to prospecting (like war and drug runners), it's one polluted by erratic confidences." More >

PDAC Kicks off with Bold Predictions
Source: Brian Sylvester of The Gold Report  (3/2/15)
The annual conference of the Prospectors and Developers Association of Canada (PDAC) is under way in Toronto and the mood on the floor and in the Investors Exchange is, as one might expect, cautiously hopeful, even if about a dozen booth spaces are unoccupied. More >

Three for Three and Going for Four: Manitok Energy's Mass Geremia
Source: Kevin Michael Grace of The Energy Report  (2/26/15)
The oil price collapse has left most of the industry reeling, but Mass Geremia remains unbowed. The president and CEO of Alberta oil and gas company Manitok Energy Inc. used hedging to protect against the worst of the downturn. In this interview with The Energy Report, Geremia explains how his strategy of prudent and efficient "old school" expansion has Manitok on track to become an intermediate producer before the end of the decade. More >

Macquarie's Brian Bagnell: Forget Peak Oil; Worry About Peak Demand
Source: Kevin Michael Grace of The Energy Report  (2/26/15)
Brian Bagnell of Macquarie Capital Markets has two caveats for investors in junior oil and gas companies: Expect extreme volatility, and don't expect oil prices above $70/barrel anytime soon. He tells the The Energy Report that the winners in this sector will demonstrate maximal efficiency and minimal costs, and that even in this time of crisis there are bargains to be had. More >

What's in a Global Mining ETF?
Source: Kip Keen, Mineweb  (2/26/15)
"The group's fortunes are tightly tied to the balance between metal supply and demand." More >

How to Beat the Herd Mentality: Highline's Michael Higgins
Source: George S. Mack of The Life Sciences Report  (2/25/15)
Michael Higgins of Highline Research Advisors believes it is absolutely vital for a sellside biotech analyst to understand what's going on outside the sector, because no stock lives on an island. The most fabulous fundamentals in the world won't propel a stock against powerful global or industry-wide headwinds. In this interview with The Life Sciences Report, Higgins, an industry veteran, discusses his methods of finding winning plays in the biotech space, and selects three names that could spike the punch in your portfolio. More >

European Investor Olivier Tielens: In a Sideways Gold Market, Explorers Offer the Most Upside
Source: Kevin Michael Grace of The Gold Report  (2/25/15)
It is a wonderful thing for miners to increase production and cut costs, says private investor Olivier Tielens. Unfortunately, in today's market, producers are not getting great prices for their gold and silver. In this interview with The Gold Report, Tielens argues that investors with positions in explorers that make discoveries realize immediate and major gains. In addition, he names four juniors with a high likelihood of positive reratings in 2015. More >

Where is the Smart Money Going in Mining? Lawrence Roulston's Answer May Surprise You
Source: Kevin Michael Grace of The Mining Report  (2/24/15)
Forget all the doom and gloom you hear about junior miners, says Lawrence Roulston, president of Quintana Resources Capital ULC. Canny investors should pay close attention to the flood of new money entering the sector and note carefully where it is going. In this interview with The Mining Report, Roulston presents a host of undervalued gold and silver miners with management that is not only advancing projects but, more important, enhancing shareholder value. As a bonus, many of these companies will likely be taken out at handsome premiums. More >

What Mining Insiders Had to Say at Indaba this Month
Source: Byron King, The Daily Reckoning  (2/24/15)
"There's a new supply-demand dynamic as China decelerates, with no other large market in position to fill the void." More >

Modest Tailwinds Could Blow Life into Mining Equities in 2015: Shane Nagle
Source: Brian Sylvester of The Gold Report  (2/23/15)
Lower oil prices in concert with currency devaluation versus the U.S. greenback in established mining jurisdictions like Mexico and Canada could translate into sustainably increased operating margins at some operations and a rally in precious and base metals equities, says Shane Nagle, mining analyst with Toronto-based National Bank Financial. In this interview with The Gold Report, Nagle selects some promising precious metals stories, along with his two top picks in the base metals space. More >

ROTH Capital's John White Pumps the Permian for Profit
Source: Tom Armistead of The Energy Report  (2/19/15)
John White has initiated coverage on several small-cap exploration and production companies in the Permian Basin, the latest of the major basins to turn in a big way from vertical oil and gas wells to horizontal fractured wells. In this interview with The Energy Report, the ROTH Capital Partners senior research analyst names five Permian players on his list of favorites. More >

CEL-SCI Corp.'s Novel Immunotherapies Set Sights on Cancer, Autoimmune Disorders and Infectious Diseases
Source: Dan Levy of The Life Sciences Report  (2/19/15)
Control and manipulation of the immune system is the underlying basis behind vaccinations in the fight against dangerous infectious diseases, but using immunotherapies to treat cancers and autoimmune disorders has been limited. That paradigm is changing, and CEL-SCI Corp. is among the companies poised to bring immunotherapy into these disease spaces. In this interview with The Life Sciences Report, Geert Kersten, CEL-SCI's CEO, describes how his company's Multikine and L.E.A.P.S. platforms can be deployed, and how investors can turn an immunotherapeutic win into profit. More >

Alphastox's Moshevich Defines the One Thing Strong Energy Juniors Share
Source: Peter Byrne of The Energy Report  (2/19/15)
The implosion of oil and gas prices will flush out oil and gas exploration juniors with weak balance sheets and too much debt, says Etienne Moshevich, editor of Alphastox.com. The small-cap companies left standing, however, are poised to soar once the market begins to accelerate. In this interview with The Energy Report, Moshevich touts the benefits of motivated management teams and solid balance sheets for all companies in the energy sector, and singles out seven oil and gas juniors, plus a pair of uranium picks, with outstanding prospects come the turnaround. More >